Clinical trialPhase 2Completed
Flouro-Gem in Adenocarcinoma of the Pancreas (GEFLUPAN)
A Phase II Trial of Flouro-Gem as a First Line Treatment of Metastatic Adenocarcinoma of the Pancreas (GEFLUPAN)
- Outcome
- Finished, no results posted
- Phase
- Phase 2
- Status
- Completed
- Study type
- Interventional
- Start
- 20 February 2021
- Expected end
- 9 July 2022
- Enrollment
- 48 participants
- Sites
- 1
- Primary outcomes
- Overall response rate (ORR)
- Sponsor
- Other
- Results posted
- No
- Last update
- 8 August 2022
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try